| Head and Neck Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 148show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 184 trials (88 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 184 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall_molecule 173 trials (70 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 173 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal_antibody 106 trials (27 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 106 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 87 trials (43 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall_molecule 65 trials (21 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 62 trials (32 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 46 trials (14 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 24 trials (14 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal_antibody 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 20 trials (13 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 20 trials (15 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Head and Neck Squamous Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |